Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Zebrafish study paves way to new treatments for Parkinson’s
Researchers found that dopamine-producing nerve cells in zebrafish are constantly being replaced by dedicated stem cells in the brain.
Species has a much higher capacity to regenerate nerve cells

New insights gained from studies into zebrafish could pave the way to new treatments for Parkinson’s disease.

Writing in the Journal of Neuroscience, scientists reveal how key brain cells that are damaged in people with Parkinson’s can be regenerated.

Parkinson’s disease is caused by the loss of nerve cells in the brain. These nerve cells are responsible for producing a chemical called dopamine.

When the cells die, the loss of dopamine can cause body movements to become slow and abnormal. Once the cells have been lost from the human brain, they cannot be replaced or repaired.

In the study, researchers found that dopamine-producing nerve cells in zebrafish are constantly being replaced by dedicated stem cells in the brain.

The researchers found the immune system plays a vital part in this process. In some parts of a zebrafish’s brain, however, the process does not work.

Understanding the immune signals that make replacement of these nerve cells could hold clues to developing treatments for humans, the scientists said.

“We were excited to find that zebrafish have a much higher regenerative capacity for dopamine neurons than humans,” said Dr Thomas Becker, of the University of Edinburgh’s Centre for Discovery Brain Sciences.

“Understanding the signals that underpin regeneration of these nerve cells could be important for identifying future treatments for Parkinson’s disease.”

Become a member or log in to add this story to your CPD history

RUMA CA&E extends survey deadline

News Story 1
 RUMA CA&E has extended the deadline for its online survey into vaccine availability.

Vets, SQPs, retailers and wholesalers will now have until Friday, 26 September at 5pm to submit their response.

The survey aims to further understanding into the vaccine supply challenges faced by the sector. It will also consider the short and long term impacts of disruption issues.

Insights are anonymous, and will be shared with industry stakeholders and government bodies.

The survey can be accessed here

Click here for more...
News Shorts
Dechra launches checklist for veterinary sustainability

Global animal health specialist Dechra has announced the world's first Veterinary Green Theatre Checklist (VGTC) to help make surgery more sustainable.

Endorsed by leading veterinary organisations, including the BEVA, BVNA and RCVS Knowledge, the checklist is designed to reduce the environmental footprint of veterinary care, while supporting better animal health outcomes.

The checklist was launched at the World Congress of Veterinary Anaesthesia and Analgesia in Paris and will be followed by an internal training and awareness campaign. For more information, visit dechra.com